Moors & Cabot’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12,400
| Closed | -$18.6K | – | 852 |
|
|
2023
Q1 | $18.6K | Hold |
12,400
| – | – | ﹤0.01% | 830 |
|
|
2022
Q4 | $14.5K | Hold |
12,400
| – | – | ﹤0.01% | 826 |
|
|
2022
Q3 | $14K | Hold |
12,400
| – | – | ﹤0.01% | 805 |
|
|
2022
Q2 | $20K | Hold |
12,400
| – | – | ﹤0.01% | 786 |
|
|
2022
Q1 | $19K | Hold |
12,400
| – | – | ﹤0.01% | 845 |
|
|
2021
Q4 | $30K | Sell |
12,400
-6,000
| -33% | -$14.5K | ﹤0.01% | 845 |
|
|
2021
Q3 | $47K | Sell |
18,400
-4,960
| -21% | -$12.7K | ﹤0.01% | 820 |
|
|
2021
Q2 | $67K | Buy |
23,360
+3,690
| +19% | +$10.6K | ﹤0.01% | 783 |
|
|
2021
Q1 | $46K | Buy |
19,670
+3,920
| +25% | +$9.17K | ﹤0.01% | 744 |
|
|
2020
Q4 | $27K | Buy |
15,750
+1,000
| +7% | +$1.71K | ﹤0.01% | 714 |
|
|
2020
Q3 | $14K | Sell |
14,750
-1,400
| -9% | -$1.33K | ﹤0.01% | 674 |
|
|
2020
Q2 | $14K | Sell |
16,150
-4,000
| -20% | -$3.47K | ﹤0.01% | 646 |
|
|
2020
Q1 | $15K | Hold |
20,150
| – | – | ﹤0.01% | 576 |
|
|
2019
Q4 | $18K | Sell |
20,150
-15,000
| -43% | -$13.4K | ﹤0.01% | 600 |
|
|
2019
Q3 | $34K | Sell |
35,150
-3,000
| -8% | -$2.9K | ﹤0.01% | 589 |
|
|
2019
Q2 | $41K | Buy |
38,150
+9,000
| +31% | +$9.67K | 0.01% | 540 |
|
|
2019
Q1 | $38K | Buy |
29,150
+3,000
| +11% | +$3.91K | 0.01% | 515 |
|
|
2018
Q4 | $25K | Sell |
26,150
-28,428
| -52% | -$27.2K | ﹤0.01% | 497 |
|
|
2018
Q3 | $111K | Buy |
54,578
+1,943
| +4% | +$3.95K | 0.01% | 560 |
|
|
2018
Q2 | $94K | Sell |
52,635
-7,292
| -12% | -$13K | 0.01% | 540 |
|
|
2018
Q1 | $141K | Buy |
59,927
+7,178
| +14% | +$16.9K | 0.02% | 549 |
|
|
2017
Q4 | $99K | Sell |
52,749
-1,006
| -2% | -$1.89K | 0.01% | 545 |
|
|
2017
Q3 | $135K | Sell |
53,755
-2,972
| -5% | -$7.46K | 0.02% | 514 |
|
|
2017
Q2 | $154K | Buy |
56,727
+11,430
| +25% | +$31K | 0.03% | 483 |
|
|
2017
Q1 | $134K | Buy |
45,297
+6,058
| +15% | +$17.9K | 0.02% | 483 |
|
|
2016
Q4 | $124K | Buy |
39,239
+26,666
| +212% | +$84.3K | 0.02% | 508 |
|
|
2016
Q3 | $44K | Buy |
+12,573
| New | +$44K | 0.01% | 530 |
|